Thompson MK, Poortmans P, Chalmers AJ, Faivre-Finn C, Hall E, Huddart RA, et al. Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? Br J Cancer. 2018;119:389–407. https://doi.org/10.1038/s41416-018-0201-z.

Article  PubMed  PubMed Central  Google Scholar 

International Atomic Energy Agency. Planning national radiotherapy services: A practical tool, human health series No. 14, IAEA, Vienna. 2011

Mitchell DG, Snyder B, Coakley F, Reinhold C, Thomas G, Amendola M, et al. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol. 2006;24:5687–94. https://doi.org/10.1200/JCO.2006.07.4799.

Article  PubMed  Google Scholar 

Chang JH, Lim Joon D, Nguyen BT, Hiew C-Y, Esler S, Angus D, et al. MRI scans significantly change target coverage decisions in radical radiotherapy for prostate cancer. J Med Imaging Radiat Oncol. 2014;58:237–43. https://doi.org/10.1111/1754-9485.12107.

Article  PubMed  Google Scholar 

Klüter Se. Technical design and concept of a 0.35 T MR-Linac. Clin Transl Radiat Oncol. 2019;18:98–101. https://doi.org/10.1016/j.ctro.2019.04.007.

Article  PubMed  PubMed Central  Google Scholar 

Winkel D, Bol GH, Kroon PS, van Asselen B, Hackett SS, Werensteijn-Honingh AM, et al. Adaptive radiotherapy: the Elekta Unity MR-linac concept. Clin Transl Radiat Oncol. 2019;18:54–9. https://doi.org/10.1016/j.ctro.2019.04.001.

Article  PubMed  PubMed Central  Google Scholar 

Thorwarth D, Low DA. Technical challenges of real-time adaptive MR-guided radiotherapy. Front Oncol. 2021;11:634507. https://doi.org/10.3389/fonc.2021.634507.

Article  PubMed  PubMed Central  Google Scholar 

Kow AWC. Hepatic metastasis from colorectal cancer. J Gastrointest Oncol. 2019;10:1274–98. https://doi.org/10.21037/jgo.2019.08.06.

Article  PubMed  PubMed Central  Google Scholar 

Ippolito E, Mertens I, Haustermans K, Gambacorta MA, Pasini D, Valentini V. IGRT in rectal cancer. Acta Oncol. 2008;47:1317–24. https://doi.org/10.1080/02841860802256459.

Article  PubMed  Google Scholar 

Nijkamp J, de Jong R, Sonke J-J, Remeijer P, van Vliet C, Marijnen C. Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients. Radiother Oncol. 2009;92:202–9. https://doi.org/10.1016/j.radonc.2009.04.022.

Article  PubMed  Google Scholar 

Brierley JD, Dawson LA, Sampson E, Bayley A, Scott S, Moseley JL, et al. Rectal motion in patients receiving preoperative radiotherapy for carcinoma of the rectum. Int J Radiat Oncol Biol Phys. 2011;80:97–102. https://doi.org/10.1016/j.ijrobp.2010.01.042.

Article  PubMed  Google Scholar 

Roels S, Slagmolen P, Nuyts J, Lee JA, Loeckx D, Maes F, et al. Biological image-guided radiotherapy in rectal cancer: challenges and pitfalls. Int J Radiat Oncol Biol Phys. 2009;75:782–90. https://doi.org/10.1016/j.ijrobp.2008.11.031.

Article  PubMed  Google Scholar 

Van den Begin R, Kleijnen J-P, Engels B, Philippens M, van Asselen B, Raaymakers B, et al. Tumor volume regression during preoperative chemoradiotherapy for rectal cancer: a prospective observational study with weekly MRI. Acta Oncol. 2018;57:723–7. https://doi.org/10.1080/0284186X.2017.1400689.

Article  PubMed  Google Scholar 

Rogowski P, von Bestenbostel R, Walter F, Straub K, Nierer L, Kurz C, et al. Feasibility and early clinical experience of online adaptive MR-guided radiotherapy of liver tumors. Cancers. 2021;13:1523. https://doi.org/10.3390/cancers13071523.

Article  PubMed  PubMed Central  Google Scholar 

Hegde JV, Cao M, Yu VY, Kishan AU, Shaverdian N, Lamb J, et al. Magnetic resonance imaging guidance mitigates the effects of intrafraction prostate motion during stereotactic body radiotherapy for prostate cancer. Cureus. 2018;10:e2442. https://doi.org/10.7759/cureus.2442.

Article  PubMed  PubMed Central  Google Scholar 

Tetar SU, Bruynzeel AME, Lagerwaard FJ, Slotman BJ, Bohoudi O, Palacios MA. Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer. Phys Imaging Radiat Oncol. 2019;9:69–76. https://doi.org/10.1016/j.phro.2019.02.002.

Article  PubMed  PubMed Central  Google Scholar 

Prins FM, Stemkens B, Kerkmeijer LGW, Barendrecht MM, de Boer HJ, Vonken E-JPA, et al. Intrafraction motion management of renal cell carcinoma with magnetic resonance imaging-guided stereotactic body radiation therapy. Pract Radiat Oncol. 2019;9:e55-61. https://doi.org/10.1016/j.prro.2018.09.002.

Article  PubMed  Google Scholar 

Kim T, Lewis BC, Price A, Mazur T, Gach HM, Park JC, et al. Direct tumor visual feedback during free breathing in 0.35T MRgRT. J Appl Clin Med Phys. 2020;21:241–7. https://doi.org/10.1002/acm2.13016.

Article  PubMed  PubMed Central  Google Scholar 

Horvat N, Rocha CCT, Oliveira BC, Petkovska I, Gollub MJ. MRI of rectal cancer tumor staging, imaging techniques, and management. Radiographics. 2019;39:367–87. https://doi.org/10.1148/rg.2019180114.

Article  PubMed  Google Scholar 

Balyasnikova S, Brown G. Optimal imaging strategies for rectal cancer staging and ongoing management. Curr Treat Options Oncol. 2016;17:32. https://doi.org/10.1007/s11864-016-0403-7.

Article  PubMed  PubMed Central  Google Scholar 

Taylor FGM, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, et al. One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br J Surg. 2011;98:872–9. https://doi.org/10.1002/bjs.7458.

CAS  Article  PubMed  Google Scholar 

Boldrini L, Placidi E, Dinapoli N, Azario L, Cellini F, Massaccesi M, et al. Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: an in silico evaluation. Tech Innov Patient Support Radiat Oncol. 2018;6:5–10. https://doi.org/10.1016/j.tipsro.2018.02.002.

Article  PubMed  PubMed Central  Google Scholar 

Chiloiro G, Boldrini L, Meldolesi E, Re A, Cellini F, Cusumano D, et al. MR-guided radiotherapy in rectal cancer: first clinical experience of an innovative technology. Clin Transl Radiat Oncol. 2019;18:80–6. https://doi.org/10.1016/j.ctro.2019.04.006. The first clinical report using MRgRT for the treatment of rectal cancer.

Article  PubMed  PubMed Central  Google Scholar 

Burbach JPM, den Harder AM, Intven M, van Vulpen M, Verkooijen HM, Reerink O. Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis. Radiother Oncol. 2014;113:1–9. https://doi.org/10.1016/j.radonc.2014.08.035.

Article  PubMed  Google Scholar 

Valentini V, Gambacorta MA, Cellini F, Aristei C, Coco C, Barbaro B, et al. The INTERACT trial: long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer. Radiother Oncol. 2019;134:110–8. https://doi.org/10.1016/j.radonc.2018.11.023.

CAS  Article  PubMed  Google Scholar 

Bonomo P, Lo Russo M, Nachbar M, Boeke S, Gatidis S, Zips D, et al. 1.5 T MR-linac planning study to compare two different strategies of rectal boost irradiation. Clin Transl Radiat Oncol. 2021;26:86–91. https://doi.org/10.1016/j.ctro.2020.11.016.

Article  PubMed  Google Scholar 

Habr-Gama A, São Julião GP, Vailati BB, Sabbaga J, Aguilar PB, Fernandez LM, et al. Organ preservation in cT2N0 rectal cancer after neoadjuvant chemoradiation therapy: the impact of radiation therapy dose-escalation and consolidation chemotherapy. Ann Surg. 2019;269:102–7. https://doi.org/10.1097/SLA.0000000000002447.

Article  PubMed  Google Scholar 

Dossa F, Chesney TR, Acuna SA, Baxter NN. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2:501–13. https://doi.org/10.1016/S2468-1253(17)30074-2.

Article  PubMed  Google Scholar 

Fernandez LM, São Julião GP, Figueiredo NL, Beets GL, van der Valk MJM, Bahadoer RR, et al. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study. Lancet Oncol. 2021;22:43–50. https://doi.org/10.1016/S1470-2045(20)30557-X.

Article  PubMed  Google Scholar 

Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg E-MK, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO) a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:29–42. https://doi.org/10.1016/S1470-2045(20)30555-6. Landmark RCT demonstrating superior outcomes with total neoadjuvant therapy compared to standard of care treatment with adjuvant chemotherapy.

CAS  Article  Google Scholar 

Conroy T, Bosset J-F, Etienne P-L, Rio E, François É, Mesgouez-Nebout N, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:702–15. https://doi.org/10.1016/S1470-2045(21)00079-6.

CAS  Article  Google Scholar 

Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol. 2007;25:4104–9. https://doi.org/10.1200/JCO.2007.11.9610.

Article  PubMed  Google Scholar 

Sun Y-S, Zhang X-P, Tang L, Ji J-F, Gu J, Cai Y, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology. 2010;254:170–8. https://doi.org/10.1148/radiol.2541082230.

Article  PubMed  Google Scholar 

Shaverdian N, Yang Y, Hu P, Hart S, Sheng K, Lamb J, et al. Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancer. Br J Radiol. 2017;90:20160739. https://doi.org/10.1259/bjr.20160739.

Article  PubMed  PubMed Central  Google Scholar 

Fu J, Zhong X, Li N, Van Dams R, Lewis J, Sung K, et al. Deep learning-based radiomic features for improving neoadjuvant chemoradiation response prediction in locally advanced rectal cancer. Phys Med Biol. 2020;65:075001. https://doi.org/10.1088/1361-6560/ab7970.

Article  PubMed  Google Scholar 

Kim H, Pedersen K, Olsen JR, Mutch MG, Chin R-I, Glasgow SC, et al. Nonoperative rectal cancer management with short-course radiation followed by chemotherapy: a nonrandomized control trial. Clin Colorectal Cancer. 2021. https://doi.org/10.1016/j.clcc.2021.03.003.

Article  PubMed  Google Scholar 

Lievens Y, Guckenberger M, Gomez D, Hoyer M, Iyengar P, Kindts I, et al. Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document. Radiother Oncol. 2020;148:157–66. https://doi.org/10.1016/j.radonc.2020.04.003.

Article  PubMed  Google Scholar 

van der Geest LGM, Lam-Boer J, Koopman M, Verhoef C, Elferink MAG, de Wilt JHW. Nationwide trends in